QUALITY CARE (SURREY) LIMITED Company accounts

COMPANY REGISTRATION NUMBER: 04916692

QUALITY CARE (SURREY) LIMITED

Financial Statements

31 March 2025

QUALITY CARE (SURREY) LIMITED

Financial Statements

Year ended 31 March 2025

Contents	Page

Strategic report	1

Director's report	4

Independent auditor's report to the members	6

Statement of comprehensive income	10

Statement of financial position	11

Statement of changes in equity	12

Statement of cash flows	13

Notes to the financial statements	14

QUALITY CARE (SURREY) LIMITED

Strategic Report

Year ended 31 March 2025

The directors present their strategic report of Quality Care (Surrey) Ltd (refer as Company) for the year ended 31 March 2025. PRINCIPAL ACTIVITY The principal activity of the company is the operation of care homes. The company remains committed to delivering a high standard of care within safe, supportive and high-quality environments. The directors consider occupancy levels to be the key performance indicator (KPI), as they directly reflect both demand for services and operational performance. During the year, the company acquired a new care home, Lynwood, which has contributed to an increase in overall income. This growth has been accompanied by corresponding increases in operating costs, reflecting the additional staffing, maintenance and running expenses associated with the new site. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES The company's principal financial instruments comprise bank balances, bank overdrafts, trade debtors, trade creditors and loans. These instruments are primarily used to fund day-to-day operations and support the company's ongoing activities. Given the nature of these financial instruments, the company is not exposed to significant price risk. Liquidity risk is managed through careful cash flow monitoring to ensure sufficient funds are available to meet liabilities as they fall due. SECTION 172(1) STATEMENT Promoting long-term success and sustainability This statement outlines how the Board has acted in a way that promotes the long-term success of the company for the benefit of its stakeholders. In its decision-making, the Board has regard to: " the impact of the company's operations on the communities in which it operates and on the environment; and " the need to maintain a strong reputation for high standards of business conduct. Engagement with key stakeholders The company conducts its business with honesty, integrity and openness, respecting human rights and the interests of employees, residents, suppliers and other third parties. The company aims to:" build strong, trust-based relationships with stakeholders; " maintain a safe and healthy working environment; " promote diversity and equality, recruiting and promoting staff based on objective criteria and capability; and " provide safe, high-quality, consistent and value-for-money care services. Residents Residents remain at the centre of the company's activities. The company has established a strong reputation for providing high-quality, inclusive care tailored to individual needs. By working closely with residents and their families, the company is able to respond effectively to changing care requirements. Key areas of focus include: " consistently high-quality care across all homes;" a positive resident experience; and " flexibility in service delivery. The Board regularly reviews reports covering key resident metrics, including occupancy levels, complaints and feedback, to assess performance and drive improvements. Staff Employees are fundamental to the company's success. The company seeks to ensure staff feel valued and supported, including paying rates above the minimum wage and providing comprehensive in-house and external training opportunities. The company's Gender Pay Gap Report demonstrates its ongoing commitment to fairness and equality in the workplace. Suppliers Suppliers play a vital role in supporting high-quality care delivery. The company is committed to:" treating suppliers fairly and with respect; " paying suppliers in accordance with agreed terms; and " working collaboratively to support improvements in social, environmental and ethical practices. Communities and environment The company recognises its environmental responsibilities and is committed to reducing the environmental impact of its operations. Key commitments include: " preventing pollution and minimising environmental impact; " reducing energy and water consumption and using renewable or recyclable resources where practicable; " minimising waste and promoting recycling;" complying with, and where possible exceeding, environmental legislation; and" providing appropriate environmental training and awareness for employees. The environmental policy is reviewed regularly to support continuous improvement and sustainable development. BUSINESS RISKS The company provides care services to elderly individuals and people with learning disabilities across Wales and England. Performance is closely linked to occupancy levels, and changes in demand may impact results. An ageing population presents opportunities for growth through increased market share and improved occupancy. The acquisition of Lynwood during the year represents a significant strategic development and supports the company's growth objectives. The company continue to explore opportunities for further expansion while monitoring costs carefully to ensure sustainable returns and operational efficiency. FUTURE DEVELOPMENTS The company will continue to invest in maintaining its care homes to a high standard. Subject to suitable opportunities arising, the company may seek to acquire additional care homes where quality and operational fit align with the existing portfolio. EMPLOYMENT OF DISABLED PERSONS The company gives full and fair consideration to applications from disabled persons and will employ or retain individuals with disabilities wherever the requirements of the role can be met. EMPLOYEE INVOLVEMENT The company maintains open communication with employees through internal communication channels and regular meetings between management and staff. Employees are encouraged to share feedback and ideas to support continuous improvement. STREAMLINED ENERGY AND CARBON REPORTING During the year, the company implemented several energy-saving initiatives, including the installation of smart electricity meters, LED lighting across all sites, A-rated gas boilers, improved pipe insulation and increased use of natural light through skylights. Solar panels have also been installed at selected locations to reduce energy consumption and carbon emissions. These initiatives support the company's commitment to environmental sustainability while also improving operational efficiency.

This report was approved by the board of directors on 31 December 2025 and signed on behalf of the board by:

S Selvakumaran
Director

Registered office:

Marlin Lodge

31 Marlborough Road

Luton

LU3 1EF

QUALITY CARE (SURREY) LIMITED

Director's Report

Year ended 31 March 2025

The director presents his report and the financial statements of the company for the year ended 31 March 2025 .

Director

The director who served the company during the year was as follows:

S Selvakumaran

Dividends

Particulars of recommended dividends are detailed in note 14 to the financial statements.

Director's responsibilities statement

The director is responsible for preparing the strategic report, director's report and the financial statements in accordance with applicable law and regulations. Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the director is required to: - select suitable accounting policies and then apply them consistently; - make judgments and accounting estimates that are reasonable and prudent; - prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Auditor

Each of the persons who is a director at the date of approval of this report confirms that:

- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

This report was approved by the board of directors on 31 December 2025 and signed on behalf of the board by:

S Selvakumaran
Director

Registered office:

Marlin Lodge

31 Marlborough Road

Luton

LU3 1EF

QUALITY CARE (SURREY) LIMITED

Independent Auditor's Report to the Members of QUALITY CARE (SURREY) LIMITED

Year ended 31 March 2025

Opinion

We have audited the financial statements of QUALITY CARE (SURREY) LIMITED (the 'company') for the year ended 31 March 2025 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity, statement of cash flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion the financial statements: - give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; - have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The director is responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

- the information given in the strategic report and the director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the director's report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the director's report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and returns; or - certain disclosures of director's remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.

Responsibilities of the director

As explained more fully in the director's responsibilities statement, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the director is responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the company or to cease operations, or has no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Identifying and responding to risks of material misstatement due to fraud: To identify risks of material misstatement due to fraud (fraud risks) we assessed events or conditions that could indicate and incentive or pressure to commit fraud or provide an opportunity to commit fraud. Our risk assessment procedure included: 1. Enquiring of director and key managements personnel as whether they have knowledge of any actual, suspected or alleged fraud. 2. Using analytical procedures to identify any unusual or unexpected relationships We communicated identified fraud risks throughout the audit team and remained alert to any indications of fraud throughout the audit. As required by auditing standards, we performed procedures to address the risk of management override of controls, in particular the risk of bias in accounting estimates and judgements such as impairment. On this audit we do not believe there is a fraud risk related to revenue recognition because there is no pressure on management to achieve an expected revenue target as as it is an owner run business. Identifying and responding to risks of material misstatements due to non-compliance with Law and regulations: We identified areas of law and regulation that could reasonably be expected to have material effect on the financial statements from our general commercial sector experience and through our discussion with Director. We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit. Firstly, the company is subject to law and regulations that directly affect the financial statements including financial reporting legislation, taxation legislation, pension legislation and we assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statements items. Secondly the company is subject to many other law and regulations where the consequences of non -compliances could have a material effect on amounts or disclosures in the financial statements, for instance through the imposition of fines and litigations. We identified the following areas as those most likely to have such an effect; Care Standards Act, Health and Social Care Act, Health and Safety, Data Protection Act(GDPR),Care Quality Commission(CQC),Employment Law. We discussed with our Audit team and director matters related to actual and suspected breaches of law and regulations, for which disclosure is not necessary and considered any implications for our audit. Our Audit procedure are designed to detected material misstatement. We are not responsible for preventing non-compliance or fraud and cannot be expected to detect non-compliance with all law and regulations. As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also: - Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. - Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control. - Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the director. - Conclude on the appropriateness of the director's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the company to cease to continue as a going concern. - Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Use of our report

This report is made solely to the company's members, as a body, in accordance with chapter 3 of part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Mohammad Saleemi

(Senior Statutory Auditor)

For and on behalf of

Saleemi Associates

Chartered accountants & statutory auditor

Registered Auditors

792 Wickham Road

Croydon CR0 8EA

31 December 2025

QUALITY CARE (SURREY) LIMITED

Statement of Comprehensive Income

Year ended 31 March 2025

		2025	2024
Note		£	£
Turnover	4	3,113,162	2,759,947

Cost of sales	1,910,825	1,546,890
	------------	------------
Gross profit	1,202,337	1,213,057

Administrative expenses		498,630	343,886
Other operating income	5	38,780	26,460
		------------	------------
Operating profit	6	742,487	895,631

Income from other fixed asset investments	10	–	32,529
Other interest receivable and similar income	11	57,094	47,112
Amounts written back to investments		–	201,216
Interest payable and similar expenses	12	–	( 898)
		------------	------------
Profit before taxation		799,581	774,954

Tax on profit	13	213,503	260,398
		---------	---------
Profit for the financial year		586,078	514,556
		---------	---------

Fair value movement in investments	–	58,783
Tax relating to components of other comprehensive income	–	( 14,696)
	----	--------
Other comprehensive income for the year	–	44,087
	---------	---------
Total comprehensive income for the year	586,078	558,643
	---------	---------

All the activities of the company are from continuing operations.

QUALITY CARE (SURREY) LIMITED

Statement of Financial Position

31 March 2025

	2025	2024
Note	£	£

Fixed assets

Intangible assets	15	101,251	1
Tangible assets	16	2,959,492	1,757,981
Investments	17	1,117,114	1,117,114
		------------	------------
		4,177,857	2,875,096

Current assets

Debtors	18	1,533,420	1,316,734
Investments	19	–	1,500,000
Cash at bank and in hand		1,023,937	341,271
		------------	------------
		2,557,357	3,158,005

Creditors: amounts falling due within one year	20	526,764	403,341
		------------	------------
Net current assets		2,030,593	2,754,664
		------------	------------
Total assets less current liabilities		6,208,450	5,629,760

Provisions	21	30,172	37,560
		------------	------------
Net assets		6,178,278	5,592,200
		------------	------------

Capital and reserves

Called up share capital	23	8	8
Capital redemption reserve	24	2	2
Other reserves, including the fair value reserve	24	44,087	44,087
Profit and loss account	24	6,134,181	5,548,103
		------------	------------
Shareholders funds		6,178,278	5,592,200
		------------	------------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the medium companies regime.

These financial statements were approved by the board of directors and authorised for issue on 31 December 2025 , and are signed on behalf of the board by:

S Selvakumaran
Director

Company registration number: 04916692

QUALITY CARE (SURREY) LIMITED

Statement of Changes in Equity

Year ended 31 March 2025

			Called up share capital	Capital redemption reserve	Other reserves, including the fair value reserve	Profit and loss account	Total
			£	£	£	£	£
At 1 April 2023			8	2	–	5,113,547	5,113,557

Profit for the year						514,556	514,556
Other comprehensive income for the year:
	Fair value movement in investments		–	–	58,783	–	58,783
	Tax relating to components of other comprehensive income	13	–	–	( 14,696)	–	( 14,696)
			----	----	--------	------------	------------
Total comprehensive income for the year			–	–	44,087	514,556	558,643

Dividends paid and payable		14	–	–	–	( 80,000)	( 80,000)
			----	----	--------	------------	------------
Total investments by and distributions to owners			–	–	–	( 80,000)	( 80,000)

At 31 March 2024			8	2	44,087	5,548,103	5,592,200

Profit for the year						586,078	586,078
			----	----	--------	------------	------------
Total comprehensive income for the year			–	–	–	586,078	586,078

			----	----	--------	------------	------------
At 31 March 2025			8	2	44,087	6,134,181	6,178,278
			----	----	--------	------------	------------

QUALITY CARE (SURREY) LIMITED

Statement of Cash Flows

Year ended 31 March 2025

	2025	2024
	£	£

Cash flows from operating activities

Profit for the financial year	586,078	514,556

Adjustments for:
Depreciation of tangible assets	55,971	82,844
Amortisation of intangible assets	33,750	–
Amounts written back to investments	–	201,216
Income from other fixed asset investments	–	( 32,529)
Other interest receivable and similar income	( 57,094)	( 47,112)
Interest payable and similar expenses	–	( 898)
Tax on profit	213,503	260,398
Accrued expenses	10,806	50,180

Changes in:
Trade and other debtors	( 216,686)	38,574
Trade and other creditors	129,260	( 38)
	---------	------------
Cash generated from operations	755,588	1,067,191

Interest paid	–	898
Interest received	57,094	47,112
Tax paid	( 237,534)	( 198,614)
	---------	------------
Net cash from operating activities	575,148	916,587
	---------	------------

Cash flows from investing activities

Purchase of tangible assets	( 1,257,482)	( 73,746)
Purchase of intangible assets	( 135,000)	–
Purchases of other investments	–	( 1,500,000)
Proceeds from sale of other investments	1,500,000	395,131
	------------	------------
Net cash from/(used in) investing activities	107,518	( 1,178,615)
	------------	------------

Cash flows from financing activities

Dividends paid	–	( 80,000)
	------------	------------
Net cash used in financing activities	–	( 80,000)
	------------	------------

Net increase/(decrease) in cash and cash equivalents	682,666	( 342,028)
Cash and cash equivalents at beginning of year	341,271	683,299
	------------	---------
Cash and cash equivalents at end of year	1,023,937	341,271
	------------	---------

QUALITY CARE (SURREY) LIMITED

Notes to the Financial Statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Marlin Lodge, 31 Marlborough Road, Luton, LU3 1EF.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	25% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Freehold property	-	1% straight line
Plant and machinery	-	25% reducing balance
Fixtures and fittings	-	25% reducing balance
Motor vehicles	-	25% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Investment property is revalued to its fair value at each reporting date and any changes in fair value are recognised in profit or loss

Investments in associates

Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Investments in joint ventures

Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Turnover

Turnover arises from:

	2025	2024
	£	£
Rendering of services	3,113,162	2,759,947
	------------	------------

The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.

5. Other operating income

	2025	2024
	£	£
Other operating income	38,780	26,460
	--------	--------

6. Operating profit

Operating profit or loss is stated after charging:

	2025	2024
	£	£
Amortisation of intangible assets	33,750	–
Depreciation of tangible assets	55,971	82,844
	--------	--------

7. Auditor's remuneration

	2025	2024
	£	£
Fees payable for the audit of the financial statements	4,000	4,000
	-------	-------

8. Staff costs

The average number of persons employed by the company during the year, including the director, amounted to:

	2025	2024
	No.	No.
Number of staff	72	67
	----	----

The aggregate payroll costs incurred during the year, relating to the above, were:

	2025	2024
	£	£
Wages and salaries	1,554,821	1,234,455
Social security costs	118,590	88,424
Other pension costs	97,960	56,360
	------------	------------
	1,771,371	1,379,239
	------------	------------

9. Director's remuneration

The director's aggregate remuneration in respect of qualifying services was:

	2025	2024
	£	£
Remuneration	80,000	40,000
	--------	--------

During the year ended 31 March 2025, the company made employer pension contributions of £80,000 (2024: £40,000) in respect of a director, Mr Selvakumaran, to a defined contribution (money purchase) pension scheme operated by Aviva Pension Trust. These contributions are included within directors’ remuneration

10. Income from other fixed asset investments

	2025	2024
	£	£
Gain/(loss) on disposal of other fixed asset investments	–	32,529
	----	--------

11. Other interest receivable and similar income

	2025	2024
	£	£
Interest on cash and cash equivalents	57,094	47,112
	--------	--------

12. Interest payable and similar expenses

	2025	2024
	£	£
Interest on banks loans and overdrafts	–	( 898)
	----	----

13. Tax on profit

Major components of tax expense

	2025	2024
	£	£

Current tax:

UK current tax expense	220,891	237,534

Deferred tax:

Origination and reversal of timing differences	( 7,388)	22,864
	---------	---------
Tax on profit	213,503	260,398
	---------	---------

Tax recognised as other comprehensive income or equity

The aggregate current and deferred tax relating to items recognised as other comprehensive income or equity for the year was £Nil (2024: £ 14,696 ).

Reconciliation of tax expense

The tax assessed on the profit on ordinary activities for the year is the same as (2024: the same as) the standard rate of corporation tax in the UK of 25 % (2024: 25 %).

	2025	2024
	£	£
Profit on ordinary activities before taxation	799,581	774,954
	---------	---------
Profit on ordinary activities by rate of tax	213,503	260,398
	---------	---------

14. Dividends

Dividends paid during the year (excluding those for which a liability existed at the end of the prior year):

	2025	2024
	£	£
Dividends on equity shares	–	80,000
	----	--------

15. Intangible assets

	Goodwill
	£
Cost
At 1 April 2024	350,000
Additions	135,000
	---------
At 31 March 2025	485,000
	---------
Amortisation
At 1 April 2024	349,999
Charge for the year	33,750
	---------
At 31 March 2025	383,749
	---------
Carrying amount
At 31 March 2025	101,251
	---------
At 31 March 2024	1
	---------

16. Tangible assets

	Freehold property	Plant and machinery	Fixtures and fittings	Motor vehicles	Total
	£	£	£	£	£
Cost
At 1 April 2024	1,695,345	451,852	73,746	52,890	2,273,833
Additions	1,253,877	3,416	189	–	1,257,482
	------------	---------	--------	--------	------------
At 31 March 2025	2,949,222	455,268	73,935	52,890	3,531,315
	------------	---------	--------	--------	------------
Depreciation
At 1 April 2024	40,688	420,364	18,437	36,363	515,852
Charge for the year	20,679	8,171	13,899	13,222	55,971
	------------	---------	--------	--------	------------
At 31 March 2025	61,367	428,535	32,336	49,585	571,823
	------------	---------	--------	--------	------------
Carrying amount
At 31 March 2025	2,887,855	26,733	41,599	3,305	2,959,492
	------------	---------	--------	--------	------------
At 31 March 2024	1,654,657	31,488	55,309	16,527	1,757,981
	------------	---------	--------	--------	------------

17. Investments

	Other investments other than loans
	£
Cost
At 1 April 2024 and 31 March 2025	1,117,114
	------------
Impairment
At 1 April 2024 and 31 March 2025	–
	------------

Carrying amount
At 31 March 2025	1,117,114
	------------
At 31 March 2024	1,117,114
	------------

Other investments includes investment properties. The fair values of these investment properties at the reporting date have been determined by the directors. In arriving at these valuations, the directors have used recent market data obtained from publicly available online property valuation tools, together with their knowledge of the properties and local market conditions.

No independent professional valuation has been obtained. Any resulting gains or losses arising from changes in fair value are recognised in profit or loss for the year.

18. Debtors

	2025	2024
	£	£
Trade debtors	676,281	507,651
Director's loan account	857,139	809,083
	------------	------------
	1,533,420	1,316,734
	------------	------------

19. Investments

	2025	2024
	£	£
Other investments	–	1,500,000
	----	------------

20. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	27,603	3,429
Accruals and deferred income	112,453	50,180
Corporation tax	220,891	237,534
Social security and other taxes	40,443	23,783
Other creditors	125,374	88,415
	---------	---------
	526,764	403,341
	---------	---------

21. Provisions

	Deferred tax (note 22)
	£
At 1 April 2024	37,560
Unused amounts reversed	( 7,388)
	--------
At 31 March 2025	30,172
	--------

22. Deferred tax

The deferred tax included in the statement of financial position is as follows:

	2025	2024
	£	£
Included in provisions (note 21)	30,172	37,560
	--------	--------

The deferred tax account consists of the tax effect of timing differences in respect of:

	2025	2024
	£	£
Accelerated capital allowances	15,476	22,864
Fair value adjustment of financial assets	25,029	25,029
Fair value adjustment of investment property	( 10,333)	( 10,333)
	--------	--------
	30,172	37,560
	--------	--------

23. Called up share capital

Issued, called up and fully paid

	2025		2024
	No.	£	No.	£
Ordinary shares of £ 1 each	8	8	8	8
	----	----	----	----

24. Reserves

		2025	2024
		£	£

Profit and loss account -brought forward	5,548,103	5,113,547
Profit and loss for the year	586,078	514,556
Dividend paid in the year	–	80,000
	------------	------------
Profit and loss account - carried forward	6,134,181	5,548,103

Capital redemption reserve	2	2
	------------	------------
TOTAL	6,134,183	5,548,105
	------------	------------

25. Analysis of changes in net debt

	At 1 Apr 2024	Cash flows	At 31 Mar 2025
	£	£	£
Cash at bank and in hand	341,271	682,666	1,023,937
Current asset investments	1,500,000	(1,500,000)	–
	------------	------------	------------
	1,841,271	( 817,334)	1,023,937
	------------	------------	------------

26. Director's advances, credits and guarantees

	2025	2024
	£	£
(advances)/credits
Director's Loan Account	(857,139)	(809,083)
	---------	---------

27. Related party transactions

1) The company was under the control of Mr S Selvakumaran throughout the current and previous year. Mr S Selvakumaran is the managing director and majority shareholder. 2) A loan of £375,563 was given to Marlin Properties Ltd ,a company solely owned by Mr. S Selvakumaran in relation to purchase of a property. This loan is repayable in 5 years with accrued interest at rate of 2.25%. 3) A loan of £830,000 is given to Mr. S Selvakumaran during the year. This Loan is unsecured loan and repayable in 2 years with accrued interest at rate of 2.25%.